Comment to the article by Arai Y, Jo T, Matsui H, Kondo T and Takaori-Kondo A: “Comparison of up-front treatments for newly diagnosed immune thrombocytopenia – a systematic review and network meta-analysis”. Haematologica 2018;103(1):163–171. Need to direct immune thrombocytopenia therapy towards shared goals

Lorenzo Cirasino,Stefano Semeraro

Comment to the article by Arai Y, Jo T, Matsui H, Kondo T and Takaori-Kondo A: “Comparison of up-front treatments for newly diagnosed immune thrombocytopenia – a systematic review and network meta-analysis”. Haematologica 2018;103(1):163–171. Need to direct immune thrombocytopenia therapy towards shared goals

2018

Lorenzo Cirasino
Stefano Semeraro

On the basis of the results of their recent work titled “Comparison of up-front treatments for newly diagnosed immune thrombocytopenia – a systematic review and network meta-analysis”, Arai and colleagues sustain that human thrombopoietin agonists may be beneficial up-front therapies in

Keywords:

Immunology
Immune system
Medicine
Thrombopoietin
newly diagnosed
immune thrombocytopenia
Meta-analysis
Diabetes mellitus

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations